University of California Irvine redefines mass spectrometry imaging with the Shimadzu iMScope QT
19 Jan 2026

Mass spectrometry imaging (MSI) is rapidly reshaping spatial biology by allowing scientists to map metabolites, lipids, and proteins directly in tissues with unprecedented clarity. In this SelectScience interview, Dr. Felix Grun, Director of the Mass Spectrometry Facility at University of California Irvine, shares how the iMScope QT from Shimadzu is transforming MSI by enabling high-resolution, high-speed spatial metabolomics and lipidomics across diverse research areas. With its atmospheric pressure MALDI design, built-in optical microscope, intuitive workflow, and powerful ImageReveal software, the Shimadzu iMScope QT is accelerating scientific discovery and opening new possibilities in spatial biology and multiomics research.
About the company
Shimadzu Corporation
Shimadzu Corporation was founded in Kyoto, Japan in 1875 and has been supplying cutting-edge analytical and measuring instruments for a broad range of applications for over 140 years. Key markets include pharmaceuticals, life sciences, food & beverages, chemicals, petrochemicals, environmental, material science, and forensics/toxicology. Products include chromatographs (HPLC/UHPLC/SFC, GC), mass spectrometers (GC-MS/MS, LC-MS/MS, MALDI, ICP-MS), spectrophotometers (FT-IR, Fluorescence, UV-VIS-NIR), atomic spectrometers (AA, ICP), X-ray spectrometers (ED-XRF, XRD, XRF), thermal analyzers, Total Organic Carbon (TOC) analyzers, particle size analyzers, material testing machines, and balances, etc.





















